Halohydrin and oxime derivatives of radicicol: synthesis and antitumor activities

Bioorg Med Chem. 2002 Nov;10(11):3445-54. doi: 10.1016/s0968-0896(02)00260-2.

Abstract

Novel halohydrin and oxime derivatives of radicicol (1) were prepared and evaluated for their v-src tyrosine kinase inhibitory, antiproliferative, and antitumor activities. Some of the resulting derivatives showed significantly improved antitumor activities than those of 1 in vitro as tested in a cell proliferation assay and in vivo using sc-inoculated human breast carcinoma and epidermoid tumor models. Design and synthesis of radicicol-based novel affinity probes are also described.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / pathology
  • Chromatography, High Pressure Liquid
  • Drug Screening Assays, Antitumor
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Indicators and Reagents
  • Lactones / chemical synthesis*
  • Lactones / pharmacokinetics
  • Lactones / pharmacology*
  • Macrolides
  • Oximes / chemical synthesis*
  • Oximes / pharmacology*
  • Structure-Activity Relationship
  • Tumor Cells, Cultured
  • src-Family Kinases / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Indicators and Reagents
  • Lactones
  • Macrolides
  • Oximes
  • src-Family Kinases
  • monorden